Prudential Financial’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,048
Closed -$873K 2510
2020
Q3
$873K Buy
3,048
+140
+5% +$32.9K ﹤0.01% 1705
2020
Q2
$548K Sell
2,908
-300
-9% -$48.8K ﹤0.01% 1896
2020
Q1
$395K Sell
3,208
-22
-0.7% -$3.44K ﹤0.01% 1980
2019
Q4
$535K Buy
3,230
+100
+3% +$16.6K ﹤0.01% 2039
2019
Q3
$383K Buy
3,130
+180
+6% +$23.9K ﹤0.01% 2127
2019
Q2
$366K Buy
2,950
+71
+2% +$9.01K ﹤0.01% 2170
2019
Q1
$380K Buy
2,879
+624
+28% +$84.2K ﹤0.01% 2163
2018
Q4
$316K Buy
+2,255
New +$299K ﹤0.01% 2129

Other funds holding ONC

Prudential Financial's ONC Position: Q4 2020 in Review

Prudential Financial sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 3,048 shares — an estimated $873K sold.

Prudential Financial first reported a position in ONC in Q4 2018 and held it in 8 quarters. The position peaked at $873K in Q3 2020. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Prudential Financial reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Prudential Financial sold 3,048 BeOne Medicines Ltd shares in Q4 2020, an estimated $873K.
  • Prudential Financial first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 8 quarters.
  • Prudential Financial's BeOne Medicines Ltd position peaked at $873K in Q3 2020.
  • 248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Prudential Financial's 13F filing for Q4 2020, filed 16 Feb 2021.